Sub-categories in digestive remedies are affected in different ways due to COVID-19. Some segments, such as mild diarrhoeal remedies, showed stronger sales in Q1 2020 due to diarrhoea being a symptom of COVID-19.
A major issue impacted the development of H2 blockers. H2 blockers are a group of medicines which reduce the amount of acid produced by the cells in the lining of the stomach and their full name is histamine H2-receptor antagonists.
Bayer Consumer Care BV holds the lead in digestive remedies in 2020 with its well-known and well trusted Rennie brand, along with Rennie being top of the list in brand terms in indigestion and heartburn remedies and antacids. Bayer holds a dominant lead in IBS treatments with its Iberogast brand, and also tops the list in proton pump inhibitors, with its Losecosan 20 brand beating even GSK Consumer Healthcare (GlaxoSmithKline Plc)’s Nexium Control by a large margin.
It is important for players in digestive remedies to adapt their product portfolios to meet changing consumer needs. For example, it has been noted that motion sickness remedies and more severe diarrhoea remedies are losing sales due to travel restrictions caused by COVID-19, and that H2 blockers have faced a significant challenge with the NDMA scare.
IBS treatments is another sub-segment which continues to see growth, as consumers become more aware of this health issue and therefore become more open to trying products which can offer relief. Additionally, IBS treatments is still a relatively new category in the Netherlands, with Iberogast by leading digestive remedies specialist, Bayer, only launched in 2011.
As evidenced by the popularity of the herbal Iberogast above, there is a growing consumer interest in more natural medicinal products. This is also coming into sharper focus in relation to the recall of H2 blockers which contained ranitidine, believed to contain traces of the carcinogenic NDMA and therefore potentially raise the risk of cancer.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Digestive Remedies industry in Netherlands with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Digestive Remedies industry in Netherlands, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Digestive Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page